Physician profile
Donato Stinghen
NPI 1083624050
$1,358.12
in general payments reported to CMS, 2019-2025
6 companies · $672 in 2025
The $672 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $11.50 · 2021: $111 · 2022: $178 · 2023: $285 · 2024: $101 · 2025: $672.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,058.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,057.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $676.28 | 2020-2025 | Grafix Pl, Oasis, Grafix |
| Kerecis Limited | $378.19 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Organogenesis INC. | $220.72 | 2021-2025 | Puraply Wound Matrix, Puraply |
| Kci USA, INC. | $39.80 | 2023 | Promogran Prisma, 3m Coban, Snap |
| Bioventus LLC | $25.64 | 2023 | |
| Mimedx Group, INC. | $17.49 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donato Stinghen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.